
IVOB
Healthcare · Medical Devices · $34.7M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2011
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Dec 31, 2018 | Time not confirmed | — | -0.01 | — |
| Nov 14, 2018 | Time not confirmed | — | -0.00 | — |
| Aug 14, 2018 | Time not confirmed | — | -0.01 | — |
| Mar 31, 2018 | Time not confirmed | — | -0.00 | — |
INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community worldwide. Its lead product, INVOcell, is a novel medical device, which is used in infertility treatment that enables egg fertilization and early embryo development in the woman's body. The company also offers INVOcell Retention Device, a single-use, modified…